259 related articles for article (PubMed ID: 34874400)
1. Bioactive cationic peptides as potential agents for breast cancer treatment.
Manrique-Moreno M; Santa-González GA; Gallego V
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34874400
[TBL] [Abstract][Full Text] [Related]
2. Bioactive Cationic Peptides as Potential Agents for Breast Cancer Treatment.
Manrique-Moreno M; Santa-González GA; Gallego V
Biosci Rep; 2021 Nov; ():. PubMed ID: 34755829
[TBL] [Abstract][Full Text] [Related]
3. Role of glycosylation in the anticancer activity of antibacterial peptides against breast cancer cells.
Han YY; Liu HY; Han DJ; Zong XC; Zhang SQ; Chen YQ
Biochem Pharmacol; 2013 Nov; 86(9):1254-62. PubMed ID: 23962446
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of antimicrobial peptides containing CisoDGRC in CD13 negative breast cancer cells.
Hou L; Zhao X; Wang P; Ning Q; Meng M; Liu C
PLoS One; 2013; 8(1):e53491. PubMed ID: 23326440
[TBL] [Abstract][Full Text] [Related]
5. Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenografts.
Hilchie AL; Doucette CD; Pinto DM; Patrzykat A; Douglas S; Hoskin DW
Breast Cancer Res; 2011 Oct; 13(5):R102. PubMed ID: 22023734
[TBL] [Abstract][Full Text] [Related]
6. Biophysical Insights into the Antitumoral Activity of Crotalicidin against Breast Cancer Model Membranes.
Klaiss-Luna MC; Giraldo-Lorza JM; Jemioła-Rzemińska M; Strzałka K; Manrique-Moreno M
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003414
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a proapoptotic peptide towards cancer cells.
Jäkel CE; Meschenmoser K; Kim Y; Weiher H; Schmidt-Wolf IG
In Vivo; 2012; 26(3):419-26. PubMed ID: 22523294
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications.
Deslouches B; Di YP
Oncotarget; 2017 Jul; 8(28):46635-46651. PubMed ID: 28422728
[TBL] [Abstract][Full Text] [Related]
9. Selective phenylalanine to proline substitution for improved antimicrobial and anticancer activities of peptides designed on phenylalanine heptad repeat.
Tripathi AK; Kumari T; Tandon A; Sayeed M; Afshan T; Kathuria M; Shukla PK; Mitra K; Ghosh JK
Acta Biomater; 2017 Jul; 57():170-186. PubMed ID: 28483698
[TBL] [Abstract][Full Text] [Related]
10. Learning from host-defense peptides: cationic, amphipathic peptoids with potent anticancer activity.
Huang W; Seo J; Willingham SB; Czyzewski AM; Gonzalgo ML; Weissman IL; Barron AE
PLoS One; 2014; 9(2):e90397. PubMed ID: 24587350
[TBL] [Abstract][Full Text] [Related]
11. Antitumor Activity and Mechanism of Action of Hormonotoxin, an LHRH Analog Conjugated to Dermaseptin-B2, a Multifunctional Antimicrobial Peptide.
Couty M; Dusaud M; Miro-Padovani M; Zhang L; Zadigue P; Zargarian L; Lequin O; de la Taille A; Delbe J; Hamma-Kourbali Y; Amiche M
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768734
[TBL] [Abstract][Full Text] [Related]
12. Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer.
Liang AL; Qian HL; Zhang TT; Zhou N; Wang HJ; Men XT; Qi W; Zhang PP; Fu M; Liang X; Lin C; Liu YJ
Drug Des Devel Ther; 2015; 9():5671-86. PubMed ID: 26527862
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effects and cell selectivity of temporin-1CEa, an antimicrobial peptide from the skin secretions of the Chinese brown frog (Rana chensinensis).
Wang C; Li HB; Li S; Tian LL; Shang DJ
Biochimie; 2012 Feb; 94(2):434-41. PubMed ID: 21871946
[TBL] [Abstract][Full Text] [Related]
14. Biophysical characterization and antitumor activity of synthetic Pantinin peptides from scorpion's venom.
Crusca E; Basso LGM; Altei WF; Marchetto R
Biochim Biophys Acta Biomembr; 2018 Nov; 1860(11):2155-2165. PubMed ID: 30409511
[TBL] [Abstract][Full Text] [Related]
15. Anticancer mechanisms of temporin-1CEa, an amphipathic α-helical antimicrobial peptide, in Bcap-37 human breast cancer cells.
Wang C; Zhou Y; Li S; Li H; Tian L; Wang H; Shang D
Life Sci; 2013 May; 92(20-21):1004-14. PubMed ID: 23583573
[TBL] [Abstract][Full Text] [Related]
16. Functional properties of a novel hybrid antimicrobial peptide NS: potent antitumor activity and efficient plasmid delivery.
Zhang Y; Song J; Zhang W; Liang R; Ma Y; Zhang L; Wei X; Ni J; Wang R
J Pept Sci; 2014 Oct; 20(10):785-93. PubMed ID: 24958615
[TBL] [Abstract][Full Text] [Related]
17. Protonectin peptides target lipids, act at the interface and selectively kill metastatic breast cancer cells while preserving morphological integrity.
Batista Martins D; Fadel V; Oliveira FD; Gaspar D; Alvares DS; Castanho MARB; Dos Santos Cabrera MP
J Colloid Interface Sci; 2021 Nov; 601():517-530. PubMed ID: 34090029
[TBL] [Abstract][Full Text] [Related]
18. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial Peptides: A Promising Avenue for Human Healthcare.
Bhopale GM
Curr Pharm Biotechnol; 2020; 21(2):90-96. PubMed ID: 31612826
[TBL] [Abstract][Full Text] [Related]
20. Natural Products as Promising Antitumoral Agents in Breast Cancer: Mechanisms of Action and Molecular Targets.
Bonofiglio D; Giordano C; De Amicis F; Lanzino M; Andò S
Mini Rev Med Chem; 2016; 16(8):596-604. PubMed ID: 26156544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
